Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michelle Le

Showing results (111-120 of 124) with videos related to

Pageof 13
Sort By:
Frontiers in Medicine|December 4, 2024
Effect of omalizumab on inflammatory markers in COVID-19: an exploratory analysis of the COVID-19 immunologic antiviral therapy with omalizumab (CIAO) trialConnor Prosty, Michelle Le, Yang Lu, et al.
Frontiers in Medicine|September 20, 2021
Systematic Review on the Efficacy and Safety of Oral Janus Kinase Inhibitors for the Treatment of Atopic DermatitisMichelle Le, Melissa Berman-Rosa, Feras M Ghazawi, et al.
Frontiers in Medicine|March 21, 2022
Population-Based Study Detailing Cutaneous Melanoma Incidence and Mortality Trends in CanadaSantina Conte, Feras M Ghazawi, Michelle Le, et al.
Dermatology (Basel, Switzerland)|June 9, 2022
Analysis of Geographic and Environmental Factors and Their Association with Cutaneous Melanoma Incidence in CanadaMelissa Berman-Rosa, James Logan, Feras M Ghazawi, et al.
AIDS (London, England)|October 3, 2003
Failures of 1 week on, 1 week off antiretroviral therapies in a randomized trialJintanat Ananworanich, Reto Nuesch, Michelle Le Braz, et al.
Leukemia|October 7, 2021
HUGO Gene Nomenclature Committee (HGNC) recommendations for the designation of gene fusionsElspeth A Bruford, Cristina R Antonescu, Andrew J Carroll, et al.
Nature|June 18, 2025
Author Correction: Collagenolysis-dependent DDR1 signalling dictates pancreatic cancer outcomeHua Su, Fei Yang, Rao Fu, et al.
Nature|March 7, 2023
Publisher Correction: Collagenolysis-dependent DDR1 signalling dictates pancreatic cancer outcomeHua Su, Fei Yang, Rao Fu, et al.
Nature|October 5, 2022
Collagenolysis-dependent DDR1 signalling dictates pancreatic cancer outcomeHua Su, Fei Yang, Rao Fu, et al.
Archives of Internal Medicine|May 28, 2003
A prospective trial of structured treatment interruptions in human immunodeficiency virus infectionCatherine Fagard, Annette Oxenius, Huldrych Günthard, et al.
Pageof 13

Showing results (111-120 of 124) with videos related to

Sort By:
Pageof 13
Frontiers in Medicine|December 4, 2024
Effect of omalizumab on inflammatory markers in COVID-19: an exploratory analysis of the COVID-19 immunologic antiviral therapy with omalizumab (CIAO) trialConnor Prosty, Michelle Le, Yang Lu, et al.
Frontiers in Medicine|September 20, 2021
Systematic Review on the Efficacy and Safety of Oral Janus Kinase Inhibitors for the Treatment of Atopic DermatitisMichelle Le, Melissa Berman-Rosa, Feras M Ghazawi, et al.
Frontiers in Medicine|March 21, 2022
Population-Based Study Detailing Cutaneous Melanoma Incidence and Mortality Trends in CanadaSantina Conte, Feras M Ghazawi, Michelle Le, et al.
Dermatology (Basel, Switzerland)|June 9, 2022
Analysis of Geographic and Environmental Factors and Their Association with Cutaneous Melanoma Incidence in CanadaMelissa Berman-Rosa, James Logan, Feras M Ghazawi, et al.
AIDS (London, England)|October 3, 2003
Failures of 1 week on, 1 week off antiretroviral therapies in a randomized trialJintanat Ananworanich, Reto Nuesch, Michelle Le Braz, et al.
Leukemia|October 7, 2021
HUGO Gene Nomenclature Committee (HGNC) recommendations for the designation of gene fusionsElspeth A Bruford, Cristina R Antonescu, Andrew J Carroll, et al.
Nature|June 18, 2025
Author Correction: Collagenolysis-dependent DDR1 signalling dictates pancreatic cancer outcomeHua Su, Fei Yang, Rao Fu, et al.
Nature|March 7, 2023
Publisher Correction: Collagenolysis-dependent DDR1 signalling dictates pancreatic cancer outcomeHua Su, Fei Yang, Rao Fu, et al.
Nature|October 5, 2022
Collagenolysis-dependent DDR1 signalling dictates pancreatic cancer outcomeHua Su, Fei Yang, Rao Fu, et al.
Archives of Internal Medicine|May 28, 2003
A prospective trial of structured treatment interruptions in human immunodeficiency virus infectionCatherine Fagard, Annette Oxenius, Huldrych Günthard, et al.
Pageof 13